1. Home
  2. ADTX vs CPHI Comparison

ADTX vs CPHI Comparison

Compare ADTX & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • CPHI
  • Stock Information
  • Founded
  • ADTX 2017
  • CPHI N/A
  • Country
  • ADTX United States
  • CPHI China
  • Employees
  • ADTX N/A
  • CPHI N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADTX Health Care
  • CPHI Health Care
  • Exchange
  • ADTX Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • ADTX 4.9M
  • CPHI 4.7M
  • IPO Year
  • ADTX 2020
  • CPHI N/A
  • Fundamental
  • Price
  • ADTX $0.67
  • CPHI $1.95
  • Analyst Decision
  • ADTX
  • CPHI
  • Analyst Count
  • ADTX 0
  • CPHI 0
  • Target Price
  • ADTX N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • ADTX 342.1K
  • CPHI 26.1K
  • Earning Date
  • ADTX 11-17-2025
  • CPHI 11-12-2025
  • Dividend Yield
  • ADTX N/A
  • CPHI N/A
  • EPS Growth
  • ADTX N/A
  • CPHI N/A
  • EPS
  • ADTX N/A
  • CPHI N/A
  • Revenue
  • ADTX $12,051.00
  • CPHI $4,396,201.00
  • Revenue This Year
  • ADTX $15,768.94
  • CPHI N/A
  • Revenue Next Year
  • ADTX N/A
  • CPHI N/A
  • P/E Ratio
  • ADTX N/A
  • CPHI N/A
  • Revenue Growth
  • ADTX N/A
  • CPHI N/A
  • 52 Week Low
  • ADTX $0.67
  • CPHI $1.20
  • 52 Week High
  • ADTX $464.98
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 26.68
  • CPHI 60.72
  • Support Level
  • ADTX $0.97
  • CPHI $1.85
  • Resistance Level
  • ADTX $0.77
  • CPHI $1.97
  • Average True Range (ATR)
  • ADTX 0.07
  • CPHI 0.11
  • MACD
  • ADTX -0.02
  • CPHI -0.01
  • Stochastic Oscillator
  • ADTX 1.51
  • CPHI 78.00

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: